Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

DSpace Repositorium (Manakin basiert)

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

Autor(en): Dreyling, Martin; Doorduijn, Jeanette; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron; Celli, Melania; Hess, Georg; Arcaini, Luca; Visco, Carlo; van Meerten, Tom; Wirths, Stefan; Zinzani, Pier Luigi; Novak, Urban; Herhaus, Peter; Benedetti, Fabio; Sonnevi, Kristina; Hanoun, Christine; Haenel, Matthias; Dierlamm, Judith; Pott, Christiane; Klapper, Wolfram; Goezel, Doendue; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco; Hoster, Eva
Tübinger Autor(en):
Wirths, Stefan
Erschienen in: Lancet (2024), Bd. 403, H. 10441, S. 2293-2306
Verlagsangabe: New York : Elsevier Science Inc
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1016/S0140-6736(24)00184-3
ISSN: 0140-6736
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: